Комплексний підхід до оцінки потенціалу фармацевтичних ринків в країнах ЄС

Abstract

The article analyzes current trends in the development of EU pharmaceutical enterprises. Possibilities of promotion of generic drugs and control over their use are evaluated on the example of some countries of the world. A comprehensive assessment of the potential of the EU pharmaceutical markets has been proposed and carried out, for which the author has selected individual indicators from the international report on health and pharmaceutical evaluation in the EU countries. Radar diagrams for standardized values of indicators of complex capacity assessment of pharmaceutical companies in the European Union have been constructed. An integral indicator of the potential assessment of pharmaceutical markets in individual EU countries has been calculated.